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ABSTRACT 
 
APPLICATIONS OF BIOMATERIALS IN CANCER DIAGNOSIS 
AND TREATMENT 
 
Damla Gözen 
M.Sc. in Molecular Biology and Genetics 
Supervisor: Assist. Prof. Dr. Kamil Can Akçalı 
July, 2013 
 
Cancer remains to be a major burden of disease worldwide, despite the significant 
increase in the number of studies that focus on the development of novel diagnostic and 
treatment strategies. Recently, important part of these studies use biomaterials and their 
biomedical applications have been investigated extensively, due to their 
biocompatibility. Among these biomaterials two of them, carbon nanotubes (CNT) and 
polymer hydrogels have gained great importance due to their unique physical and 
chemical properties. The current study proposes new approaches that take advantage of 
these two biomaterials which could be used in the treatment and diagnosis of 
hepatocellular carcinoma (HCC).  We first proposed the usage of CNTs as novel 
diagnostic tools for the determination of the aggressiveness of HCC. Two cell lines with 
different epithelial-to-mesenchymal (EMT) status, HUH7 and Snu182 were used and 
their attachment features on patterned CNT surfaces were compared. Our SEM images 
and MTT results revealed that the cells with epithelial phenotype (HUH7) attach and 
proliferate more on CNTs than the cells with mesenchymal phenotype (Snu182) which 
makes these surfaces promising diagnostic tools to differentiate HCC according to their 
aggressiveness. Secondly, polymer hydrogels with Dox release were suggested to be 
promising therapeutics to cure HCC. Our cell viability and cytotoxicity tests showed the 
inhibition of the proliferation of HCC line, SNU398 in the presence of drug-releasing 
hydrogels. This suggests the usage of hydrogels as drug delivery vehicles to have 
enhanced therapeutic efficacies in the HCC therapies.     
Keywords: Biomaterials, CNTs, polymer hydrogels, cancer, treatment, diagnosis.   
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ÖZET 
 
BİYOMATERYALLERİN KANSER TEŞHİS VE TEDAVİSİNDEKİ 
KULLANIMI 
 
Damla Gözen 
Moleküler Biyoloji ve Genetik, Yüksek Lisans Tezi 
Tez Yöneticisi: Yard. Doç. Dr. Kamil Can Akçalı 
Temmuz, 2013 
 
Günümüzde birçok bilimsel çalışma kanser teşhis ve tedavisinde yeni ve daha etkili 
stratejiler geliştirmeye odaklanmış olsa da kanser hala dünyadaki başlıca hastalık 
nedenlerinden biridir. Bu çalışmalardan önemli bir kısmı biyomateryallerin biyolojik 
uyumlu özelliğinden dolayı biyomedikal alandaki uygulamalarını araştırmaya 
yönelmiştir. Bu biomateryaller arasında karbon nanotüpler (KNT) ve polimer hidrojeller 
eşsiz fiziksel ve kimyasal özellikleri sayesinde büyük önem kazanmaktadırlar. Bu 
çalışma bu iki  biyomateryalin özelliklerinden yaralanarak karaciğer kanseri teşhis ve 
tedavisi için yeni yaklaşımlar getirmeyi amaçlamaktadır. İlk olarak, karaciğer kanserinin 
agresifliğini belirlemek için teşhis esnasında KNTlerin kullanımı test edildi. Değişik 
epitel ve mezenkimal fenotipteki iki hücre hattının, HUH7 ve Snu182, KNT yüzeyleri 
üzerindeki yapışma özellikleri karşılaştırıldı. Taramalı elektron mikroskobunda elde 
edilen görüntüler ve MTT sonuçları epitel fenotipteki HUH7 hücrelerinin KNT yüzeyler 
üzerindeki yapışma ve büyümesinin mezenkimal fenotipteki Snu182 hücrelerine göre 
daha fazla olduğunu göstermiştir. Bu sonuç KNT yüzeylerinin karaciğer kanserinin 
agresifliğini belirlemek için kullanılabileceğini göstermektedir. Bu çalışmadaki ikinci 
hedefimiz, Dox içeren polimer hidrojellerin karaciğer kanseri tedavisinde etkili olarak 
kullanılabileceğini göstermekti. Yapılan hücre sayım ve sitotoksisite testleri ile  
karaciğer kanseri hücre hattı Snu398in çoğalmasının ilaç içeren hidrojellerin varlığında 
engellendiği gösterilmiştir. Bu sonuçlar, hidrojellerin ilaç taşıyıcısı olarak 
kullanıldığında kaaciğer kanseri tedavisinin tesirini arttırabileceğini öne sürmektedir.                     
Keywords: Biyomateryaller, KNT, polimer hidrojeller, kanser, tedavi, teşhis.   
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Chapter 1 
Introduction 
Cancer is a major public health problem worldwide. The number of patients diagnosed 
with cancer has been increasing each year [1]. Recently, many studies have been 
performed to find novel diagnostic strategies for early and easier recognition of the 
disease and determination of its stage. There is also a huge interest in the studies 
focusing on the development of new therapies with increased efficacy and decreased 
side effects.  
Along with other fields, biomaterial and nanotechnology research gain great importance 
in biomedical applications; especially in cancer diagnosis and treatment; due to their 
biocompatible characteristics. They have been studied for targeted drug delivery, gene 
delivery, chemotherapy and tumor imaging as well as many other uses. The studies of 
application of biomaterials to develop safer medicines with increased treatment efficacy 
have promising results. [2–4] Two of these biomaterials; Carbon nanotubes (CNT) and 
polymer hydrogels have shown considerable promise both in cancer diagnosis and 
therapy. [5,6] 
2 
 
The current study proposes new approaches that take advantage of two biomaterials, 
CNTs and hydrogels which could be used in the treatment and diagnosis of 
Hepatocellular carcinoma.  CNTs are proposed as novel diagnostic tools for the 
determination of the aggressiveness of Hepatocellular Carcinoma (HCC); while polymer 
hydrogels with Dox release are suggested to be promising therapeutics to cure HCC.  
In order to understand the application of these biomaterials in treatment and diagnosis of 
HCC, the first part of the introduction of this thesis includes some information about 
HCC. Then, the use of VA-CNTs in HCC diagnosis and the use of hydrogels in the 
treatment of HCC would be explained in further parts.  
1.1 Hepatocellular Carcinoma 
Hepatocellular carcinoma (HCC) is an epithelial cancer with one of the worst prognosis 
among the other cancers. There are many causes of HCC development such as HBV and 
HCV infections, alcohol and tobacco consumption, aflotixin B1, obesity, etc [7] (Figure 
1.1). HCC can occur after inflammation and fibrosis resulting in cirrhosis. It is among 
the most aggressive cancers [7] and early diagnosis is very important in the effective 
treatment of it [8]. 
 
 
Figure 1.1 [9].  Mechanisms for Hepatocellular carcinogenesis 
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HCC has four stages including well differentiated, moderately differentiated, poorly 
differentiated and undifferentiated tumors. The poorly differentiated cells gain 
mesenchymal phenotype through Epithelial-to-Mesenchymal Transition (EMT) to 
become more independent from the underlying tissue, with increased capacity to invade 
and metastase [10]. 
HCC is the 5
th
 common cause of cancer related death. Many treatment strategies 
including surgical resection, liver transplantation and radiation are used for cure; but 
they are only efficient when the tumor is in the early stage. Most of the patients have 
HCC in advanced stage due to the late diagnosis; and in that case the commonly used 
treatment strategy is chemotherapy; to which HCC is generally resistant. This leads to 
decreased treatment efficacy.  
1.2  The Use of VA-CNTs in HCC Diagnosis 
Cancer is a devastating disease and responsible for high mortality rates [11]. The 
aggressiveness of a cancer cell depends on its interaction with neighboring cellular 
structure and the metastasis of these cells to distant organs is one of the main causes of 
cancer mortality [12,13]. Hence, the factors that regulate the attachment of cancer cells 
are one of the heavily studied areas of biology. Epithelial-to-Mesenchymal Transition 
(EMT) is one of the processes that has important roles in the prevention of the adhesion 
of cancer cells; leading to an increase in invasiveness and metastatic potentials [14]. 
Hence, the determination of the EMT status of a cancer cell during diagnosis is an 
important step for the efficiency of the treatment.   
1.2.1 Epithelial-to-Mesenchymal Transition (EMT) 
During development, EMT is a normal physiological process that has critical roles in 
embryogenesis. Epithelial and mesenchymal cells are two different cell types with 
distinct cell morphologies and functions [14]. The cells with epithelial characteristic are 
polarized and immobile; which are attached to each other and interact with basement 
membrane. On the other hand, cells in mesenchymal phenotype lose their polarity to 
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become more migratory, invasive and resistant to apoptosis with distinct morphology, 
protein expression and gene signatures.  
EMT is the process which is initiated by several steps including; activation of 
transcription factors such as Twist and Snail, expression of specific proteins and 
microRNAs, reorganization of cytoskeleton and production of   certain enzymes as a 
result of which an epithelial cell gain mesenchymal characteristic (Figure 1.2). EMT and 
the reverse process MET are required for several steps of embryogenesis including 
mesoderman and endodermal mesenchyme formation. They are also essential for tissue 
regeneration and organ fibrosis. [15,16] 
Figure 1.2 [15]: Epithelial-to-Mesenchymal Transition. 
The cells undergoing EMT typically lose the expression of epithelial cell markers such 
as E-cadherin, and gain mesenchymal marker expressions, like α-SMA, N-Cadherin, 
vimentin and fibronectin [16]. (Figure 1.2) 
Many in vivo studies have demonstrated that tumor cells can gain mesenchymal 
phenotype by the activation of EMT-inducing transcription factors such as Sail, Slug, 
ZEB1 and Twist. The tumors in early stage undergoing EMT process become aggressive 
malignancies with the prevention of adhesion; leading to increased invasiveness, 
metastasis and survival abilities [17,18] (Figure 1.3) 
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Figure 1.3 [15]: Contribution of EMT to cancer progression. 
1.2.2 Use of CNTs in Cancer Diagnosis 
Based on their cellular responses, the nature and type of cancer cells can be 
characterized. Novel strategies have been developed to classify and characterize the 
stage of cancer cells. The nanostructured materials such as nanowires [19], metal 
nanoparticles [20,21] and quantum dots [22] have been widely used both for cancer 
treatment and diagnostic applications. Among these nanostructures, the recent advances 
in the field of biomaterials have opened a new era for the use of CNTs to figure out the 
cellular interactions [23].  
CNTs are single or multilayered cylindrical structures which consist of carbon 
allotropes. They are widely used in biomaterial studies because of their unique electronic 
and mechanical properties; which make them suitable tools for tumor imaging, gene and 
drug delivery [2]. There are many studies reporting the use of CNTs as nanofibrous 
scaffold for living cells [24–29]. Furthermore, the unique electronic, mechanical and 
chemical properties bring CNTs forward out of other nanostructured materials as a 
promising tool for the detection of different types of cancer cells (oral, prostate and lung 
cancers) not only by taking advantage of functionalizing and binding specific markers 
on CNTs [30–35] but also by deriving benefit from their rigid surface properties for 
entrapping cancer cells [36,37].  
1.3     The Use of Hydrogels in Cancer Treatment 
Since chemotherapy and radiotherapy give damage to healthy tissues and cells, novel 
treatment strategies are necessary to cure HCC more effectively with the aim of 
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destroying only tumor cells without damaging the body tissues. [38–41]  Recently, 
various combinations of chemotherapeutic agents have been studied and some promising 
results have been taken from phase II studies of the combinational use of Doxorubicin, 
5-fluorouracil, cisplatin and interferon Alfa. [42,43]  
1.3.1 Doxorubicin 
Doxorubicin (Dox) is isolated from Streptomyces peucetius var. Caesius cultures. As it 
is mentioned in the drug description, it is an anthracycline antibiotic which is cytotoxic 
to cells. It is used as a compound with hydrochloride and the chemical compound is 
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-
7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride 
(8S-cis)-. The structural formula is presented in Figure 1.4.  
 
Figure 1.4: The structural formula of Doxorubucin. 
Dox interacts with nucleic acids and binds to cell membranes as well as plasma proteins. 
Its cytotoxic effects are due to this nucleotide base intercalation, which inhibits DNA 
replication and RNA transcription by preventing DNA and RNA polymerase activity 
[44]. The binding of Dox to the cell membrane also has some effects on enzymatic 
activity of the cells by generating free radical formation. This characteristic of Dox 
make it cardiotoxic due to Cu(II) and Fe(III) reduction [45]. Due to these interactions, 
Dox treatment results in morphological changes in cells, leading to apoptosis. 
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(http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1fd148fb-0fbc-4b6f-b790-
23546fb46a71#nlm34089-3) 
Although it is a promising drug for HCC treatment, Dox has many side effects, since it 
is also toxic to normal tissues; which limits its clinical use. There are many studies to 
overcome the side effects, including finding new delivery systems to directly target the 
tumor cells.  Once the toxicity of the drug to the normal cells is prevented, it is a 
promising agent for HCC treatment due to its strong antitumor activity. The animal 
studies also showed the effects of Dox activity on tumors, by inducing toxic effects [44]. 
Dox hydrochloride compound is approved by FDA as a safe and effective drug. The 
nanoencapsulated form of the compound cannot be absorbed from the gastrointestinal 
tract and is not stable in gastric acid, so iv administration was found to be the best way 
for cancer treatment, for now[39] (http:// pubchem.ncbi.nlm.nih.gov 
/summary/summary.cgi? cid=31703&loc=ec_rcs).  
1.3.2 Hydrogels and Cancer Treatment 
Although many drugs are being used in the treatment of cancer, they have short half-
lives and therefore the efficacy of the therapy largely depends on the way that the drug is 
administered. One approach to increase the duration of the in vivo effects of the drug is 
the use of a delivery vehicle to load the drug. Hydrogel is such a biomaterial that allows 
continuous drug release, increasing treatment efficacy. [46]   
Hydrogels are insoluble, hydrophilic polymers that are able to absorb water in very large 
amounts. They swell as they retain water and this property of hydrogels come from the 
hydrophilic functional groups, network elasticity, porous structures that they have and 
the cross-link density. [47] Recently, they have been investigated extensively; because 
of their potential use in biomedical applications. Their similarity to soft tissues makes 
them promising tools for drug delivery, clinical and plastic surgery, interventional 
therapy, etc. [48,49] 
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Fully swollen hydrogels have very similar properties to living tissues; therefore they 
have reduced irritation to the surrounding tissues. The hydrogel surface and body fluid 
have low interfacial tension; which decreases protein adsorption and cell adhesion to the 
surface, decreasing the probability of the stimulation of an immune response. In 
addition, they can be modified by the addition of multiple drug molecules; which can be 
administered for controlled release of drug; making them effective drug delivery 
vehicles. Coupling anticancer drugs to hydrogels is a promising strategy due to their 
good chemical stability and high biocompatibility. The toxic effects of free drug can be 
reduced with the controlled release of it by hydrogel in the target area. The characteristic 
of polymers provide enhanced drug residence time and tissue permeability, increasing 
the treatment efficacy.  In this system, the amount of drug needed is also decreased, 
lowering the cost. [49,50]      
Recently, several hydrogel-drug conjugates with the controlled drug release have been 
developed. One of these conjugates that is being investigated extensively is the 
hydrogels loaded with Dox. The highly toxic property of this drug damage normal tissue 
and to prevent the possible side effects a controlled release of the drugs could be 
provided by this hydrogel conjugate.    
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1.4  Subject and outline of the Thesis 
1.4.1 The Use of VA-CNTs in HCC Diagnosis 
HCC is a common cancer with high mortality rates, worldwide. Many treatment 
strategies in HCC therapy are only efficient when the tumor is in the early stage. 
However, most of the patients have HCC in advanced stage when diagnosed; due to the 
late recognition; which leads to decreased treatment efficacy. [38–40]  Thus, novel 
strategies for diagnosis are necessary.   
In this thesis, firstly, we have focused on a new approach to detect the invasiveness and 
metastatic degree of cancer cells based on their EMT status, by using patterned VA-
CNTs as a potential diagnostic tool without any further surface functionalization. By 
using this tool; EMT status of the tumor cells could be determined; which is an indicator 
of the stage and aggressiveness of the tumor. This result could be assessed during 
diagnosis to determine the most suitable therapy strategy according to the stage of the 
tumor.  
1.4.2 The Use of Hydrogels in Cancer Treatment  
Recently, many studies have been performed with several classes of chemotherapeutics 
and the efficacy of their use as single or combinational regimens as cancer therapy has 
been assessed in great detail. However, due to high occurrence rates of many tumors and 
their low response rates to the current treatments, novel strategies with increased 
treatment efficacy remains to be determined. HCC is one of the most common cancer 
type for which more efficient treatment strategies are needed to overcome the limitations 
and side effects of the existing ones. [1,43,51] 
In the thesis, secondly, we tested the antitumor effects of different formulations of 
polymer hydrogels with continuous release of Dox on Snu398 human HCC line. The 
results were evaluated by the comparison with the antitumor activity of drug free 
counterparts of these hydrogels in the same conditions.  
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Chapter 2 
Materials and Methods 
2.1   Materials 
2.1.1 Synthesis of VA-CNTs 
VA-CNTs were prepared with Bilkent University, Department of Chemistry, Assist. 
Prof. Dr. Erman Bengü’s group. They were grown by alcohol catalyzed chemical vapor 
deposition (ACCVD) method on oxidized Si (100) surfaces as described before in a 
previous study [26]. Sandwich catalyst layers (Al/Co/Al) were prepared for the growth 
of VA-CNTs by using the electron beam and thermal evaporation techniques [26]. Si 
substrates with the aforementioned layers were introduced into the ACCVD furnace for 
the growth of VA-CNTs through reduction and reaction steps using ethanol as a carbon 
source at temperature of 625°C under flowing H2 and Ar gases (20 sccm and 100 sccm, 
respectively). After the growth, patterning was induced to the VA- CNTs by using a 
dropper filled with deionized water. Following this step, 1µg/µl sterilized collagen 
solution was added by a micropipette onto some of the patterned CNTs for every cm
2
 
(approximately 10:1 weight ratio of collagen to CNT), resulting in two separate groups 
of patterned CNT arrays; one non-coated and the other collagen coated.  
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2.1.2 Preparation of the Dox-releasing p(HPMA/PEG–MEMA) 
hydrogel films formulation 
The Dox-releasing hydrogels were prepared in Gazi University, Department of 
Chemistry, by Prof. Dr. Gülay Bayramoğlu. Here, the protocol used to prepare the 
different formulations is explained briefly. The Poly(Hydroxypropyl methacrylate/ 
polyethylene glycole-methylether methacrylate) (p(HPMA/PEG–MEMA)) hydrogel 
formulations in the film form were prepared using UV-induced redox polymerization 
process. To test the effects of PEG chains length on the drug entrapment efficiency and 
release rates, PEG-MEMA macromonomers with three different averages Mn (i.e., 300, 
475, and 950) were used in the initial polymerization mixture, and here after the 
formulations were referred to p(HPMA/PEG-300)X1, p(HPMA/PEG–475)X1, and 
p(HPMA/PEG–950)X1, respectively. The monomer (hydroxypropyl methacrylate; 0.75 
mL), macro-monomer (polyethylene glycole-methylether; methacrylate, 0.75 mL) cross-
linker (i.e., N,N-methylenebisacrylamide; 10 mg, it was donated by X), amonium 
persulphate (5.0 mg), TEMED (10L from 10% solution w/v), absolute ethanol (0.5 
mL) were transferred in phosphate buffer (1.0 mL, 50 mM, pH 7.0). To test the effects 
of the cross-linker density on the film properties and drug-release efficiency in the initial 
polymerization mixture, the amount of added BisAA were varied between 10 and 40 mg, 
and the same amount macromonomer PEG–MEMA-300 was used as described above. 
Here after, the formulations were referred as p(HPMA/PEG–300)X1 p(HPMA/PEG–
300)X2 p(HPMA/PEG–300)X3. These resulting mixtures were equilibrated at 4°C for 
30 min in a thermostatic water bath. Each polymerization mixture was transferred in a 
flat glass mould (internal diameter: 6.5 cm). After sealing, a nitrogen atmosphere was 
created by purging nitrogen gas for 5 min, it was then exposed to UV radiation (TUW 
series, Philips; UV-C, 254-nm short wave, 24 W, Ankara, Turkey) for 30 min. The 
hydrogels obtained were cut into disks by means of a perforator (0.75 cm in diameter 
and about 600 m in thickness), and stored at 4°C in the same buffer until use. For the 
preparation of drug-loaded formulations, Dox-HCl was supplied from Fresenius Ltd., 
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UK and it was added to the polymerization mixture in two different concentrations (0.25 
or 0.5 mg/mL). 
2.1.3 Cell Culture 
We used two human HCC lines (Snu182 and HUH7) in the first experimental part: The 
use of VA-CNTs for HCC diagnosis. Snu182 is poorly differentiated and HUH7 is well 
differentiated hepatocellular cancer cell line. For the second part; the use of hydrogels in 
cancer treatment; we used Snu398 HCC line to test the effects of DOX-releasing 
hydrogels. Snu182 and SNU398 cells were cultured in RPMI medium (LONZA). HUH7 
cells were cultured in DMEM medium (LONZA). Both mediums were supplemented 
with 10% fetal bovine serum, 1% non-essential amino acids and 1% 
Penicillin/Streptomycin antibiotic. 
2.1.4 Standard Buffers and Solutions 
 
Ingredients of the standard solutions and buffers mentioned throughout the Materials and 
Methods section is given in the Appendix Section. 
2.2   Methods 
2.2.1 Total RNA isolation 
When the cells were 80-90% confluent, they were trypsinated at 37°C for 3-5 minutes. 
After the inhibition of the trypsin with the appropriate media, the cells were centrifuged 
at 1500 rpm for 3 minutes. Total RNAs were extracted from the precipitate according to 
the manufacturer’s protocol of NucleoSpin RNA II Kit (MN Macherey-Nagel, Duren, 
Germany). NanoDrop ND-1000 (NanoDrop Technologies, USA) was used to measure 
the concentrations and the OD260 and OD280 values of the RNA samples.  
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2.2.2 Synthesis of cDNAs 
ProtoScript M-MuLV First Strand cDNA Synthesis Kit (New England Biolabs) was 
used to prepare cDNAs from the isolated total RNA samples according to the 
manufacturer’s protocol. 2 μg RNA was used for each reaction with a total volume of 40 
μl.  
2.2.3 Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR) 
Primers were designed by using the online Primer3 v.0.4.0 (http://frodo.wi.mit.edu 
/primer3/) and NCBI primer BLAST tools (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/). The amplifications were performed using Taq DNA Polymerase with Standart 
Taq (Mg-free) Buffer kit (New England, BioLabs) according to the manufacturer’s 
protocol. The primers and product sizes were listed in Table 2.1.  
 
Table 2.1: Primers used in RT-PCR 
Gene Name Product 
Size 
Forward Primer (5’-3’) Reverse Primer (5’-3’) TM 
°C 
E-Cadherin 119 GACTCGTAACGACGTTGCAC  GGTCAGTATCAGCCGCTTTC 60 
Vimentin 110 GCAGGAGGAGATGCTTCAGA  ATTCCACTTTGCGTTCAAGG 60 
Fibronectin 108 AATATCTCGGTGCCATTTGC  CAGTAGTGCCTTCGGGACTG 60 
-SMA 165 TATCAGGGGGCACCACTATG  GCTGGAAGGTGGACAGAGAG 60 
N-Cadherin 139 TCCAGACCCCAATTCAATTAATATTAC AAAATCACCATTAAGCCGAGTGA 60 
Slug 159 CTTTTTCTTGCCCTCACTGC AGCAGCCAGATTCCTCATGT 60 
Twist1 201 GGAGTCCGCAGTCTTACGAG TCTGGAGGACCTGGTAGAGG 60 
SIP1 132 TGTAGATGGTCCAGAAGAAATGAA  TTGGCAAAGTATTCCTCAAAATCT 60 
GAPDH 119 GGCTGAGAACGGGAAGCTTGTCAT  CAGCCTTCTCCATGGTGGTGAAGA 60 
 
The content of the reaction mixture that was used in RT-PCR is shown in Table 2.2. 
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Table 2.2: The contents of the reaction mixture 
Ingredients Volume (l) 
cDNA 1 
10x Taq Reaction Buffer 2.5 
10 mM dNTP 0.5 
50 mM MgCl2 1.5 
Forward Primer 1 
Reverse Primer 1 
Taq Polymerase 0.2 
ddH2O 17.3 
Total 25 
 
The conditions for the RT-PCR was common for all of the primers and it is shown in 
Table 2.3. 
 
Table 2.3: The steps of the RT-PCR 
Step Temperature °C Duration Cycles 
Initial Denaturation 94 30 sec.  
Denaturation 94 30 sec.  
Annealing 60 30 sec. 
Extension 68 30 sec. 
Final Extension 68 5 min.  
 
 
2.2.4 Agarose Gel Electrophoresis 
1.5% agarose gel was prepared in 1XTAE Buffer and ethidium bromide (30ng/mL) was 
added into the solution. 6X Agarose Gel Loading Dye was used to prepare the samples 
with the final concentration of 1X and they were loaded on gel to be ran at 100 V for 30 
30 cycles 
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minutes. 100 bp Gene Ruler DNA Ladder Mix was used as marker. Transiluminator was 
used for visualization and the gel photos were taken with ChemiCap software.   
2.2.5 Imaging of the Cells on VA-CNTSs 
The VA-CNTs were placed in 6-well plates. 3x10
5
 cells of each cell line were culture on 
each well in 3 ml medium. A negative control group with VA-CNT excluding any 
cultured cells was also prepared. At the 3
rd
 day of cell culture, the cells were washed 
with PBS and prepared for imaging by scanning electron microscope (SEM) at low 
vacuum mode (40 bar) and accelerating voltage of 10 kV.  
2.2.6 Determination of Cell Proliferation Rates on VA-CNTs 
The VA-CNTs were placed in 96-well plates in triplicates. 10
4
 cancer cells of each type 
were cultured on each well in 100 l medium. Roche® Cell Proliferation Kit I (MTT) 
was used to perform the assay and all the steps were done according to the 
manufacturer’s protocol. At the 3rd day of culturing, 10 l/well MTT Labeling Reagent 
was added. After a 4-hour-incubation in a humidified incubator, 100 l/well 
Solubilization Solution was added and the samples were left for incubation in 
humidified incubator, O/N. The readings were done by using an ELISA reader at the 
wavelength value of 551 nm.  
For the calculations, the average value of background group readings was subtracted 
from all of the sample readings. The average value of control group readings were taken 
as 100% cell proliferation and the percentage of cell proliferation of each cell on the 
VA-CNTs were calculated by direct proportion.  
2.2.7 Antitumor activity of Dox loaded hydrogel formulations 
The different Dox-relasing hydrogel formulations and their counterparts without drug 
release were placed in 24-well plates in triplicates. 3x10
4
 SNU398 cells were cultured on 
each well in 1.0 mL medium. Control group with 3x10
4
 cells cultured directly without 
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any hydrogel was also included. The medium was changed at day 3 and cell counting 
was performed at day 6 with a hemocytometer after trypsinization. 
2.2.8 Cytotoxicity of biomolecules on cells 
The VA-CNTs and polymer hydrogels were placed in 96-well plates in triplicates. 2x10
4
 
cancer cells of each type were cultured on wells in 200 l medium. LDH Cytotoxicity 
Detection Kit (Clontech®) was used to measure the cytotoxicity according to the 
manufacturer’s protocol. Two control groups, high control (HC) and low control (LC) 
were also included, in which the cells were cultured directly on bare plate surface. In the 
LC group, 200 l medium was added onto the cells in order to test the minimum 
cytotoxicity, while in the HC group 1% Triton-X was added into the medium to test the 
maximum cytotoxicity value for each cell line. The readings were performed by using an 
ELISA reader at the wavelength value of 490 nm. For the calculations, the average value 
of background group readings was subtracted from all of the sample readings. 
2.2.9 Controlled release studies of Dox from the hydrogel film 
formulations 
The in vitro release studies were conducted in Gazi University, Department of 
Chemistry, by Prof. Dr. Gülay Bayramoğlu, in a continuous flow system with constant 
stirring. Here, the protocol is explained briefly. Dox-loaded five different hydrogel 
formulations (0.5 g) were placed in the continuous flow drug-release cell, and a 
physiological buffer solution (pH 7.4) was introduced through the bottom inlet port of 
the flow cell at a flow rate of 10 mL/h at 37°C with a peristaltic pump (model IPC, 
Ismatec, Düsseldorf, Germany). The effluent was collected at predetermined time 
intervals, and the released Dox (at a maximum wavelength of 490 nm) was determined 
spectrophotometrically (model 1601, Shimadzu). The analyzed solution was added back 
to the collected dissolution media to maintain a constant volume. To study the effect of 
the Dox loading on the release rate, similar procedures were followed for 0.5, and 1.0 
mg/mL drug-loaded samples. All experiments were repeated three times to minimize the 
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error variation. Therefore, the data presented in the graphs show the average values of 
three experiments. The model drug concentration in the collected dissolution medium 
was calculated with a calibration curve obtained from samples of known concentrations.  
2.2.10 Statistical Analysis 
All the results were analyzed with ANOVA. Minitab® 15 Statistical Software was used 
to make multiple comparisons of control to experimental groups. All the comparisons 
were performed using Fisher’s test with 95% confidential interval. The graphs were 
drawn by the usage of GraphPad® program.   
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Chapter 3 
Results 
3.1 The Use of CNTs in Cancer Diagnosis 
3.1.1 Preparation of VA-CNTs 
VA-CNTs were synthesized through ACCVD method on Si substrates using sandwich 
catalyst design (Al/Co/Al) as reported in a previous study [26]. They were observed 
under SEM and the side view of the images revealed that the height of the CNTs were 
10 µm whereas the average diameters of the CNTs were around 10 nm, which was 
shown by TEM analysis (Figure 3.1a). Before the cell culturing step on CNTs, we 
created asperities on VA-CNTS for the growth. This patterning step was induced by 
dropping deionized water on these surfaces. As a result of water contact, some of the 
aligned CNTs were collapsed which were surrounded by standing CNTs; forming 
cavities (Figure 3.1b). The average width of these cavities was measured as 10 µm. The 
mechanism behind the formation of self-assembled patterning is based on the elasto-
capillary effect and hydrophobic property of aligned CNTs [26,52]. Following 
aforementioned patterning process, patterned CNTs were either treated with collagen or 
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not. The experimental design of patterning was shown in Figure 3.1c. We generated two 
surfaces designated as patterned non-coated and collagen coated CNT surfaces. 
 
Figure 3.1: (a) Side view SEM images of VA-CNTs. Inset shows TEM image of CNTs. 
(b) Top view SEM image of patterned CNT surface with the inset showing a high 
magnified image from the side of pockets. (c) Schematic representation of CNT surfaces 
after patterning and collagen coating.  
3.1.2 EMT Marker Expressions of HCC 
The EMT marker expression profiles of two HCC lines; HUH7 and Snu182 were 
monitored at mRNA level (Figure 3.2). Our RT-PCR results showed that SNU182 cell 
line was positive for the expression of all of the mesenchymal markers tested; except 
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SIP1 (Vimentin, Fibronectin, a-Sma, N-Cad, Slug, Twist1). In contrary to SNU182, only 
two of the tested mesenchymal markers (Vimentin and N-Cad) were expressed in HUH7 
cells. Hence the expression profiles of these cell lines confirmed that SNU182 cells are 
poorly differentiated whereas HUH7 cells are well differentiated HCC cell line [10]. In 
parallel to previous reports, these results also indicated that HUH7 had a more epithelial 
characteristic compared to SNU182 cells [10].   
 
Figure 3.2: EMT expressions of HUH7 and SNU182 cell lines at m-RNA level. 
3.1.3 Proliferation and attachment of HCCs on patterned CNTs 
After the CNT surfaces were modified and sterilized by UV for one hour, poor 
(SNU182) and well (HUH7) differentiated HCC s were cultured on both non-coated and 
collagen coated patterned CNT surfaces. The cells were incubated for 3 days on the 
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patterned CNT surfaces and at the 3
rd
 day of culture, low vacuum SEM imaging was 
performed to assess the relationship between their differentiation levels and attachment 
ability both on collagen coated and non-coated patterned CNT surfaces (figure 3.3). In 
order to compare the number of attached cells on patterned CNTs, we counted the 
attached cells under SEM and calculated the average areal cell density by dividing the 
total cell number on the surface to total surface area. The density plot given in Figure 
3.3e indicates that the average attached cell number for well differentiated HUH7 cells 
were higher than the number of attached poor differentiated Snu182 cells on CNT 
surfaces. The difference between the areal density of well and poor differentiated cells 
was statistically significant. This suggests that patterned CNT surfaces could be used as 
tools for the definition of the differentiation level and EMT status of HCCs by taking 
advantage of the difference in the attachment rates. 
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Figure 3.3: Low vacuum SEM images of HUH7 and SNU182 cancer cells after seeded 
and cultured for 3 days on (a,c) collagen coated and (b,d) non-coated patterned CNT 
surfaces, respectively.   
In many studies, collagen is used as a coat in cell culture systems [53]. In our study, 
collagen was used as a coating on patterned CNTs instead of composite usage where a 
significant effect was observed. The number of well differentiated cells on non-coated 
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patterned CNTs was comparably higher than the ones on collagen coated surfaces. 
Contrarily, there was no significant effect of collagen coating for poor differentiated 
cells (Figure 3.3e). It is already well known that surface topography has great effects on 
the attachment abilities of cells [54]. Since collagen coating would smoothen the 
patterned CNT surfaces by infiltrating and filling the voids between each CNT, the 
addition of collagen results in decreased surface area as it was shown in Figure 3.4. 
Thereby, less surface area that is available for cell attachment would result in less 
number of cell attachment and growth on collagen coated surfaces. Our results suggest 
that the difference in the attachment ability of poor and well differentiated HCC lines on 
non-coated CNT surfaces could be used for evaluating the differentiation level and thus 
aggressiveness of HCC lines.    
 
Figure 3.4: High vacuum SEM image of a collagen coated patterned CNT surface.   
In addition to the imaging of the attached cells on patterned CNT surfaces, we 
performed MTT assay to measure the viability of the two cell lines on both non-coated 
and collagen coated patterned CNT surfaces (Figure 3.5). It is important to note that the 
reading of control group was obtained from cells on 96-well culture plates excluding 
CNT surfaces. Although cell viabilities for both cell lines decrease when compared to 
the control, our results showed that the viability of HUH7 cells were more on non-coated 
patterned CNTs when compared to the viability of SNU182 (Figure 3.5) and the 
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difference was statistically significant. Thus, our MTT data, together with the SEM 
images and the areal density data revealed that the proliferation and attachment rate of 
HUH7 is more than Snu182 on patterned CNT surfaces, making CNT a promising tool 
for the evaluation of the differentiation level of the tumor.  
 
Figure 3.5: MTT assay of cancer cells on non-coated and collagen coated CNT surfaces. 
Control group represent the case where there is no CNT surface. 
Toxicity of CNTs has been a controversial issue for researchers since there are 
conflicting reports on their toxicity [55–57]. Therefore, in order to investigate the 
cytotoxic effect of patterned CNT surfaces on HCC lines we performed LDH 
cytotoxicity analysis both on collagen coated and non-coated patterned CNTs (Figure 
3.6). In LDH test, two control groups were used; low control (LC) and high control (HC) 
in which HCCs were seeded directly on bare plate surfaces.  LC group shows the 
minimum LDH release while HC represents the maximum release. The closer the 
absorbance readings of the samples to HC, the more cytotoxic the conditions are for that 
sample. Our LDH results clearly showed that HUH7 and SNU182 cell lines have 
minimum LDH release when cultured both on the non-coated and coated patterned 
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CNTs. This result indicates that CNTs are not cytotoxic for these HCC lines when used 
as surfaces for the attachment of the cells. This data also suggests that the difference in 
the attachment rates of the two cell lines are due to difference in cells’ interaction 
characteristics with CNT surfaces; not because of the cytotoxic effects of the CNT 
surfaces. Therefore, the WD HCC line, HUH7 has greater tendency to attach on CNT 
surface when compared to the PD HCC line Snu182. 
 
Figure 3.6: LDH assay of cancer cells on non-coated and collagen coated CNT surfaces. 
Low control (LC) and high control (HC) groups represent the case where there is no 
CNT surface.  
3.2 The Use of Hydrogels in Treatment of Cancer  
3.2.1 The characteristics of the Dox-releasing hydrogels  
We used Dox-releasing and Dox-free hydrogel networks consisting of 
poly(hydroxypropyl methacrylate, and polyethylene glycole-methylether methacrylate) 
with five different PEG chain length and crosslinker amount combinations to investigate 
the effects of the drug release on the proliferation of Snu398 human HCC line. Two 
different concentrations (I1: 1.0 mg/ml and I2: 0.5 mg/ml) of drug were used to load the 
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hydrogels. The preparation and characterization of them were done by Prof. Dr. Gülay 
Bayramoğlu, as mentioned in Materials and Methods section. For the characterization of 
the hydrogels FTIR, SEM, swelling, permeability and contact angle studies were 
performed. In these studies, five formulations; p(HPMA/PEG-300)X1, p(HPMA/PEG–
475)X1, p(HPMA/PEG–950)X1, p(HPMA/PEG-300)X2, and p(HPMA/PEG–300)X3 
were used as the most effective drug release systems. 
The entrapment efficiency (%) of a drug depends on the type of matrix material, 
entrapment method of the drug and the polymer networks preparation conditions. In this 
study, it was shown that the drug-loading efficiency of the hydrogel film formulations 
depend on the PEG chain length and crosslinker density of the formulations (Table 3.1). 
The permeability to Dox was found to be increased as the PEG chain lengths in the 
hydrogel formulations increased due to the higher hydrophilicity of the hydrogel. As 
seen in Table 3.1 the p(HPMA/PEG-950)X1 formulation had the highest PEG chain 
length and therefore had a substantially higher water content and a permeability to Dox; 
while this permeability decreases as the length of PEG chain decrease to 300 from 950. 
Additionally, as the crosslinker density increased from X1 to X3, Dox-loading efficiency 
of the hydrogel formulations increased and the drug release rate decreased.  
In the same study, by the protein adsorption tests, it was shown that the increase in the 
PEG chain lengths create pulsive force against the negatively charged blood proteins 
resulting in the reduction in the adsorbed protein amounts. This characteristic of the 
hydrogel formulations make them suitable tools to deliver drugs with minimum protein 
adsorption.    
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Table 3.1: Formulation of hydrogels and their density, water content, permeability 
to Dox and drug loading efficiencies. 
 
Hydrogel formulations 
Monomer ratio 
HPMA/PEG-
MEMA 
(mmoL/mmoL) 
Cross- 
linker 
(moL) 
Density  
(g/cm
3
) 
Water 
content  
(%) 
Permeability to 
doxorubicin  
(cm
2
/s x10
-9
) 
Drug 
loading 
efficiency 
(%) 
p(HPMA/PEG-950)X1 5.55/0.80 6.5 1.036 579 91.36 75 
p(HPMA/PEG-475)X1 5.55/1.71 6.5 1.089 433 79.64 81 
p(HPMA/PEG-300)X1 5.55/2.63 6.5 1.103  171 32.83 84 
p(HPMA/PEG-300)X2 5.55/2.63 12.7 1.158 107 19.81 86 
p(HPMA/PEG-300)X3 5.55/2.63 19.2 1.176 77 12.35 89 
 
3.2.2 In vitro Dox-release studies 
Drug release from hydrogel matrices is affected by many factors, such as their swelling 
properties, network porosity, and the erosion of the hydrogel matrix, as well as drug–
polymer interactions (REF). In this study, the effects of the PEG chain length of the 
macromonomer (i.e., PEG–MEMA), cross-linker density and the amount of loaded drug 
on the Dox release were studied in a continuous drug release system. The kinetics of 
drug release from p(HPMA/PEG–MEMA) formulations were also analyzed. The effect 
of the PEG chain length of the macromonomer on the Dox release kinetics for the 
p(HPMA/PEG-300)X1, p(HPMA/PEG-475)X1, and p(HPMA/PEG-950)X1 
formulations are presented in Figure 3.7. The release profiles indicate that the amount of 
Dox released and the rate of the release increased when the PEG chain length of the 
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hydrogel increased. The p(HPMA/PEG-300)X1 hydrogel films showed 60.3% release, 
whereas the p(HPMA/PEG-475)X1 and p(HPMA/PEG-950)X1 hydrogel films showed 
85.4 and 98.3% release, respectively at 37°C and 480 min with 1.0 mg/mL Dox loading 
(Figure 3.7B). These results should be attributed to the more hydrophilic nature of the 
p(HPMA/PEG-950)X1 hydrogel formulations (Table 3.1). 
 
Figure 3.7: The effect of the PEG chains length of the macromonomer on the Dox 
release kinetics for the p(HPMA/PEG-300)X1, p(HPMA/PEG-475)X1, and 
p(HPMA/PEG-950)X1 at 0.5 mg/mL and (B) 1.0 mg/mL drug loading 
The release profiles of Dox in p(HPMA/PEG-300)X1, p(HPMA/PEG-300)X2, and 
p(HPMA/PEG–300)X3 hydrogel formulations, cross-linked with different ratios of 
BisAA, are shown in Figure 3.8. It showed that the release rate of Dox for the  
p(HPMA/PEG-300)X1 hydrogel formulation was higher and faster than those for the 
p(HPMA/PEG-300)X2 and p(HPMA/PEG–300)X3 formulations. This was due to the 
lower cross-linking density and higher swelling ratio of p(HPMA/PEG-300)X1. Figure 
3.8 shows the cumulative Dox release profiles for the hydrogel formulations. The 
p(HPMA/PEG-300)X1 hydrogel films showed 60.3% release, whereas the 
 
 
B) A) 
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p(HPMA/PEG-300)X2 and p(HPMA/PEG-300)X3 hydrogel films showed 53.2 and 
43.1% release, respectively, at 37°C and 480 min with 1.0 mg/mL Dox loading. The 
initial release rate of the drug from the hydrogels was rapid, and this initial fast release 
may be attributed to the rapid diffusion of Dox that was loaded close to the surface of 
the hydrogels. Later on, the drug was released more slowly from the hydrogels. 
 
Figure 3.8: The effect of the cross-linker density on the Dox release kinetics for the 
p(HPMA/PEG-300)X1, p(HPMA/PEG-300)X2, and p(HPMA/PEG-300)X3 at 0.5 
mg/mL and (B) 1.0 mg/mL drug loading. 
The hydrogel formulations had similar release profiles, despite different Dox contents. 
This indicates that at a lower drug concentration, most of the drug molecules remained 
bound to the polymeric chains of the hydrogels, whereas at a higher drug concentration, 
the percentage of unbound drug molecules increased in the polymer networks. The 
maximum Dox release for the p(HPMA/PEG-950)X1 hydrogel formulation with 
different drug amounts loaded (0.5 and 1.0 mg/mL) was determined to be 61.3 and 
98.3% after 480 min, respectively. Dox is freely soluble in a physiological phosphate 
 
 
 
A) B) 
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buffer (pH 7.4); as a result, the rate of depletion of the drug in the polymer at a high 
concentration was faster than at a low concentration.  
3.2.3 The effects of drug releasing hydrogels on the proliferation 
features of cancer cells 
After the hydrogel formulations were sterilized by UV for 1 hour, Snu398 cells were 
seeded on 24-well plates and all formulations of hydrogels, including counterparts 
without drug release were added into the wells. The Snu398 cells were trypsinized and 
counted at the 6
th
 day of culture by hemocytometer. Graphs showing the cell numbers 
were drawn to assess the relationship between the drug release and proliferation features 
of the HCC in the absence and presence of Dox (Figure 3.9). 
Our results showed that the number of Snu398 cells was decreased, significantly, when 
they were cultured in the presence of all five Dox-releasing hydrogel formulations 
(Figure 3.9). We did not see any significant difference in the cell numbers in the 
presence of the two different concentrations of Dox (I1 and I2). The hydrogels alone 
were found to have no effects on the cell proliferations when there is no drug release. It 
is important to note that at Day 0, 3x10
4 
cells were seeded on each well and the control 
group was excluding hydrogels. At the 6
th
 date of the culture, the increase in the cell 
number of the control group was 30 fold higher. Similar increase in the cell numbers 
were detected when the counterparts of the formulations without drug release were 
present. In addition, Dox release decreased the proliferation of Snu398 cells up to 90 
fold for all formulations. These results indicate that Dox-releasing hydrogels prevent the 
proliferation of Snu398 cells, in vitro and can be used as a promising strategy to treat 
HCC.   
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Figure 3.9: The cell numbers of Snu398 cells in the presence of different formulation of 
Dox releasing hydrogels, counted at the 6
th
 day of culture. D0 represents the initial 
number of cells seeded at the 1
st
 day and the control group represents the cell numbers at 
Day 6 where hydrogels were excluded. 
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In order to investigate the cytotoxic effects of the drug-releasing hydrogels and their 
counterparts without drug release on the HCC line, we performed LDH cytotoxicity 
analysis (Figure 3.10). In LDH test, two control groups were used as it was explained in 
the first part; LC and HC in which HCCs were seeded on bare plate surfaces.  The closer 
the absorbance readings of the samples to HC, the more cytotoxic the conditions are for 
that sample. Our LDH results clearly showed that, the drug-free counterparts of all 
hydrogel formulations were not cytotoxic to Snu398 cells since the absorbance values 
were very similar to the LC. In addition, the cytotoxicity of most of the formulations 
were increased when they were loaded with Dox and 1 mg/ml (I1) Dox-loaded 
p(HPMA/PEG-300)X3 formulation was found to be the most cytotoxic hydrogel to the 
cells. This data, together with the cell number analysis show that the usage of Dox-
releasing hydrogels has cytotoxic effects on Snu398 cells as a result of which cell 
proliferation is inhibited.  
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Figure 3.10: LDH assay of Snu398 cells in the presence of different formulation of Dox 
releasing hydrogels. Low control (LC) and high control (HC) groups represent the case 
where there is no hydrogel. 
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Chapter 4 
Discussion 
Biomaterials have been studied extensively for their biomedical applications including 
cancer research. The biocompatibility and safety of these materials make them 
promising tools for the cancer therapy and diagnosis. Previous studies showed the usage 
of different biomaterials in targeted drug delivery[58], gene delivery[59] and tumor 
imaging[60]; resulting in increased treatment and diagnostic efficacies. Among these 
biomaterials, CNTs and polymer hydrogels have gained great importance due to their 
unique physical, electrical and chemical properties [2–4].    
CNTs have gained considerable attention in biomaterial studies for their applications in 
tumor imaging, gene and drug delivery[2]. In many studies CNTs were used as 
nanofiber scaffolds for living cells by mimicking the collagen network in connective 
tissues and designing them with similar structure to native extracellular matrix (ECM)
24–
29,54
. By binding specific markers on CNTs, researchers were able to detect various types 
of cancer cells such as lung and prostate cancer[30–35]. Furthermore, in a previous 
study, CNTs were used as arrays to differentially entrap colon cancer cells with two 
different metastatic grades by taking advantage of their rigid surface properties. It was 
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reported that higher metastatic cancer cells entrapped more compared to the lower 
metastatic ones and this was explained by the morphology differences of cells at 
different grades [36]. Moreover, by the same group, it was shown that biosensors made 
of VA-CNTs could be used for the detection of cancer by entrapping them on VA-CNTs 
[37]. However, in these studies, only the difference in deformability properties of cancer 
cells with different metastatic grades was taken into consideration. Until the current 
study, there was not any study that examined the differential attachment features of 
cancer cells with different EMT status on CNTs.  
In this study, firstly, we examined the difference in attachment of HCC lines with 
different EMT status on patterned CNT surfaces to find out a facile way to differentiate 
the cells according to their aggressiveness. Two cell lines HUH7 and Snu182 were used. 
The EMT marker expression results revealed that HUH7 had a more epithelial 
characteristic compared to SNU182 cells, which were in mesenchymal phenotype. 
Regarding to our SEM and MTT results well differentiated HUH7 cells attached more 
both on collagen coated and non-coated patterned CNT surfaces than the poor 
differentiated SNU182 cells. This suggest that the difference in the attachment ability of 
poor and well differentiated HCC lines on patterned CNT surfaces could be used for 
evaluating the differentiation level and thus aggressiveness of HCC lines making them 
promising diagnostic tools.      
There are many conflicting results on the toxic effects of CNTs to cells[62]. Many 
studies state that they do not have any cytotoxic effects[25,56]. Yet, relatively few 
studies report the health hazards that might be related to these biomaterials[55,63]. 
According to these studies, CNTs cause cell damage, genotoxicity and carcinogenicity 
due to their effects on cell signaling, membrane perturbation and the production of 
cytokines, chemokines and reactive oxygen species (ROS), hence, decreasing cell 
viability[64]. These cytotoxic effects were found to depend on the presence of large 
amounts of catalysts such as Co and Fe, which can generate ROS in cellular 
environments [63,64]. Nevertheless, CNTs can be in variety of forms with difference in 
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their surface chemistries, processing methods, lengths, diameters, contaminants, and 
more and all of these variations affect the cytotoxicity of these materials[63].      
In the current study, in order to test the cytotoxic effect of patterned CNT surfaces on 
HCC lines we performed LDH cytotoxicity analysis. LDH is normally a cytoplasmic 
enzyme and it is not secreted outside of the cells. However, upon damage to the cell 
membrane, LDH leaks out. By using the LDH cytotoxicity analysis, it is possible to 
measure the release of LDH from cells based on a colorimetric quantitation. According 
to our results, CNTs were found to have no cytotoxic effects on the attached cells. 
Therefore, it can be concluded that CNTs are not cytotoxic to the cells when used as 
surfaces for the attachment of the cancer cells as explained in this study. Moreover, the 
difference in the attachment features of the WD and PD HCC lines are not due to any 
possible cytotoxic effect of CNTs, preventing the attachment of cells. It was the result of 
the difference in the cells own interaction characteristics with CNTs and this makes 
CNTs promising tools to differentiate HCC according to their EMT status by taking 
advantage of the difference in their attachment features.       
Recently, there are many potent drugs which are used in the treatment of HCC. 
However, the efficacies of them are constrained by their side effects, limited cellular 
entry and drug resistance. Most of the drugs also have very short half-lives under 
physiological conditions. Because of these reasons the efficacy of a cancer therapy 
largely depends on the way that the drug is administered and it is important to develop 
efficient delivery systems to enhance cellular uptake and decrease any possible harm 
given to normal body tissues[46].  
One of the novel approaches to increase the duration of the in vivo effects of the drug is 
to use vehicles for the drug delivery. Polymer hydrogel is such a biomaterial that allows 
continuous drug release in the target area, increasing treatment efficacy and decreasing 
side effects[46].  Recently, research on hydrogels have gain great importance; because 
of their potential use in biomedical applications, especially in drug delivery, clinical and 
plastic surgery, interventional therapy, and more[48,49]. They are reported to have very 
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similar properties to living tissues and this prevents the recognition of the material as 
foreign by body, reducing irritation to the normal tissues. In addition, they are designed 
to keep the protein adsorption and cell adhesion in minimum level, which inhibits any 
possible harm given to the normal cells. Because of their high biocompatibility and 
stability, they could be coupled with anticancer drugs to use them as drug delivery 
vehicles. With this system, many studies showed that toxicity of free drug can be 
reduced because of the controlled release of it in the target area.[49,50]   
Numerous hydrogel-drug formulations have been developed for controlled release of 
active ingredient over time. Poly(hydroxypropyl methacrylate), p(HPMA) and its 
copolymer hydrogels have found extensive applications in the biomedical field because 
of their good chemical stability and high biocompatibility. Poly(ethylene glycol) (PEG) 
is a water-soluble, nontoxic, and non-immunogenic polymer. Hydrogels containing PEG 
are interesting biomaterials because they exhibit low degrees of protein adsorption and 
cell adhesion.  
In this study, secondly, we used different formulations of p(HPMA/PEG-MEMA) 
hydrogels with Dox release and tested the effects of the drug on the proliferation of HCC 
to propose the usage of this biomaterial as novel way in drug administration. The amino 
groups of Dox are positively charged at pH 7.4 and the Lewis acid groups (γ-) of the 
PEG molecules have partially negative charge. Thus, in this hydrogel system, polymer 
and drug can interact electrostatically at pH 7.4. Snu398 was used as the HCC line. Our 
results clearly show that release of Dox significantly decreased the proliferation of HCC 
when compared to the cell proliferations in the presence of hydrogels without drug-
release. These results suggest the usage of hydrogels in HCC treatment. Further, by 
LDH cytotoxicity assay, the cytotoxic effects of the different formulations of Dox 
releasing hydrogels and their counterparts without drug release on Snu398 cells were 
tested. Our results showed that the hydrogels without any drug release were not 
cytotoxic to HCC, as it was expected. However, the cytotoxicity of the formulations 
were increased significantly when they were loaded with Dox and p(HPMA/PEG-
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300)X3 was found to be the most cytotoxic hydrogel. Overall, these results indicate that 
Dox- releasing p(HPMA/PEG-300)X3 formulation was found to be  the most effective 
formulation among the five formulations due to their significant cytotoxic effects and 
the inhibition of the proliferation of cells.   
The proposed novel administrative strategy is promising for the treatment of HCC due to 
the controlled drug release, which will increase the drug residence time leading to more 
efficient therapy. The amount of drug needed for the therapy is decreased and this 
lowers the cost. It is possible to place these hydrogels near tumor cells which will 
decrease the damage given to the normal body tissues, inhibiting the possibility of side 
effects.    
Overall, in this study, it was shown that patterned CNT surfaces are promising 
diagnostic tools for the determination of the EMT status and therefore the 
aggressiveness of tumors, which may be useful for the early detection and 
characterization of tumors. It was also shown that Dox-loaded hydrogels could be used 
in the treatment of HCC, with increased efficacy and decreased side effects.   
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Chapter 5 
Future Perspective 
In order to better understand the difference in the attachment features of tumor cells 
according to their aggressiveness on CNTs, first of all, usage of more HCC lines with 
different epithelial and mesenchymal phenotypes could be very informative to see 
whether the difference in the attachment rates of WD and PD cells is also true for other 
cell lines. Once it is tested, primary tumor cells acquired from patients could be 
examined for their attachment behaviors on CNTs, which could be an important data 
since it would represent a better experimental model for tumor behavior.  
For the examination of the effects of drug-releasing hydrogels on HCC, the usage of 
additional cell lines and primary tumor cells could also be necessary. Further, in vivo 
protocols should be used. HCC mouse models would be suitable for this step. By placing 
the hydrogel in the tumor area, the effects of drug release on the tumor size and the 
overall survival of the organism could be tested which would give a better idea about the 
efficacy of this administration method in the cancer treatment.       
Once the efficiencies of each biomaterial in cancer diagnosis and treatment of HCC is 
further proved by these experimental steps, they could also be modified for other cancer 
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types. These modifications could include preparation of different patterns on CNTs with 
increased capability to differentiate the tumor cells according to EMT status, the trial of 
different formulations of hydrogels to optimize the effects according to the tissue type 
and the usage of other drug conjugates.       
Therefore, the final application of these biomaterials would be as follows: During the 
diagnosis of a HCC patient, pathological sample would be taken from the tumor by 
biopsy. Some of these tumor cells would be cultured on CNTs which would be designed 
as chips to determine the EMT status and aggressiveness of the tumor cells. By 
evaluating the attachment features of the tumor cells on these chips, the aggressiveness 
of the tumor would be determined. This information would be used to choose the most 
appropriate therapy strategy for increased treatment efficacy. During the treatment of a 
HCC patient, Dox-releasing hydrogels would be placed directly to the tumor area. Dox 
release would kill the cancer cells in that target area, which would decrease the side 
effects of the drug and increase the treatment efficacy.   
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Appendix  
STANDARD SOLUTIONS AND BUFFERS 
DEPC-Treated ddH2O 
 1ml DEPC 
 1lt ddH2O 
 Stirred in a hood for 1 hour, autoclaved in order to inactivate the DEPC 
10X PBS 
 80 g NaCl 
 g KCl 
 8,01g Na2HPO4.2H2O 
 2g KH2PO4 
 1 liter ddH2O pH: 7,2 
 Working solution (1XPBS) was prepared by diluting 10XPBS by 10 times 
 
49 
 
50X TAE Buffer 
 2M Tris Base (242 g) 
 57,1 ml Glacial Acetic Acid 
 50mM EDTA 
 Add to 1 lt by ddH2O 
 Working solution (1XTAE) prepared by diluting 50XTAE. 
10X Agarose Gel Loading Dye 
 0,009g BFB 
 0,009g XC 
 2,8mL ddH2O 
 1,2ml 0,5M EDTA. 
 Total volume brought to 15ml by adding glycerol, dilute 1:10 in sample prior to 
loading to electrophoresis gel 
Low Glucose DMEM and RPMI-1640  
 10 % : 50 ml FBS (Regular FBS = inactivated at 55°C ) 
 5 ml Penicillin/Streptomycin (50 µg/ml final concentration from 10 mg/ml stock) 
 5 ml Non-Essential Amino Acids Solution, (diluted into 1x from 100x 
concentrate stock) 
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